Author
Steven E. Nissen
Recent research
- Health & Medicine
Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a)
BackgroundPelacarsen, an antisense oligonucleotide, reduces serum levels of lipoprotein(a). However, the effect of pelacarsen on cardiovascular outcomes remains uncertain. MethodsWe conducted an international, randomized, placebo-controlled trial involving patients with preexisti...
- Health & MedicineOpen access
Bariatric Surgery as a Rescue Strategy After Semaglutide or Tirzepatide
OBJECTIVE: To evaluate 2-year weight loss after bariatric surgery among adults with intolerable adverse effects or inadequate weight loss with semaglutide or tirzepatide. SUMMARY BACKGROUND DATA: Semaglutide and tirzepatide are effective obesity medications, but intolerance and i...